Qasim, W;
(2019)
Allogeneic CAR T cell therapies for leukemia.
American Journal of Hematology
, 94
(S1)
S50-S54.
10.1002/ajh.25399.
Preview |
Text
Qasim_Allo CAR AJH 2018 16301231.pdf - Accepted Version Download (307kB) | Preview |
Abstract
Allogeneic chimeric antigen receptor T (CAR T) cells can offer advantages over autologous T cell therapies, including the availability of 'fit' cells for production, and elimination of risks associated with inadvertent transduction of leukemic blasts. However, allogeneic T cell therapies must address HLA barriers and conventionally rely on the availability of a suitable HLA-matched donor if graft-versus-host-disease and rejection effects are to be avoided. More recently, the incorporation of additional genome editing manipulations, to disrupt T cell receptor expression and address other critical pathways have been explored. Clinical trials are underway investigating non-HLA matched T cells expressing anti-CD19 CARs for the treatment of B cell acute lymphoblastic leukaemia (B-ALL) and anti-CD123 CAR for acute myeloid leukemia (AML). Such approaches continue to be refined and improved to widen accessibility and reduce the cost of T cell therapies for a wider range of conditions.
| Type: | Article |
|---|---|
| Title: | Allogeneic CAR T cell therapies for leukemia |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1002/ajh.25399 |
| Publisher version: | https://doi.org/10.1002/ajh.25399 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | CAR-T cells, Genome Editing, Allogeneic T cells, CRISPR/Cas9, TALEN, Base editing |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Infection, Immunity and Inflammation Dept |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10065795 |
Archive Staff Only
 |
View Item |
